Cancer Drug May Halt Parkinson’s Spread
Click here to view original web page at Cancer Drug May Halt Parkinson’s Spread Summary: Researchers discovered a novel therapeutic target for Parkinson’s disease, the Aplp1 protein, which facilitates the spread of harmful alpha-synuclein proteins in the brain. Notably, an FDA-approved cancer drug targeting Lag3, a protein that interacts with Aplp1, has shown promise in … Continue reading “Cancer Drug May Halt Parkinson’s Spread”